Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SALT LAKE CITY--(BUSINESS WIRE)--The medical device innovator Dolor Technologies today announced the U.S. availability of its patented, breakthrough drug delivery catheter, SphenoCath™. SphenoCath is a single-use, disposable catheter that delivers medication through the nasal passages to a difficult-to-reach ganglion located at the back of the nose without needles, sprays, swabs or sedation. When used as indicated, SpenoCath saturates and sustains the medication immediately proximate to the ganglion to achieve a Sphenoplatine Ganglion or SPG block. Interventional radiologists, neurologists, internists, emergency departments and pain specialists are interested in utilizing SphenoCath for a safe, comfortable and quick delivery of the medication required for the SPG block procedure.
Help employers find you! Check out all the jobs and post your resume.
